TherapeuticsMD TXMD 深 沪
等待开盘 11-06 09:30:00 美东时间
1.71
-0.110
-6.04%
华盛通- 最 高1.82
- 今 开1.82
- 成交量 1.24万股
- 最 低 1.71
- 昨 收 1.82
- 总市值 1979.22万
- 52周最高 2.95
- 市盈率 静 --
- 换手率 0.11%
- 52周最低 1.43
- 委 比 93.01%
- 总股本 1157.44万
- 历史最高 563.00
- 量 比 1.19
- 振 幅 6.04%
- 历史最低 0.70
- 每 手 1
- 风险率 0.24%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多TherapeuticsMD Inc.收涨0.56%，成交额1.53万美元
11月3日，TherapeuticsMD Inc.（TXMD）收涨0.56%，报1.81美元，成交额1.53万美元，市值2094.96万美元。 行情数据 • 开...
11-03 08:44
TherapeuticsMD Inc.收平，成交额1.14万美元
10月27日，TherapeuticsMD Inc.（TXMD）收平，报1.8美元，成交额1.14万美元，市值2083.39万美元。 行情数据 • 开盘价：1...
10-27 07:46
TherapeuticsMD Inc.收跌1.55%，成交额6.24万美元
10月20-22日上海黄浦江畔，2026可持续全球领导者大会再度来袭。诺奖、图灵奖得主现场讲述科技未来与趋势，更有“解救”焦虑、内卷时代的网红教授——麦克法兰与...
10-17 07:50
TherapeuticsMD Q2 EPS $0.01 Down From $0.05 YoY, Sales $869.000K Down From $952.000K YoY
TherapeuticsMD (NASDAQ:TXMD) reported quarterly earnings of $0.01 per share. This is a 80 percent decrease over earnings of $0.05 per share from the same period last year. The company reported $869.000 thousand in sales this quarter. This is a 8.72 percent decrease over sales of $952.000 thousand th...
08-12 04:30
TherapeuticsMD Says Company Continues To Evaluate Strategic Alternatives, Including Acquisition Or Merger
The Company continues to evaluate a variety of strategic alternatives that may include, but are not limited to, an acquisition, merger, other business combination, sale of assets, or other strategic transactions
05-13 05:47
TherapeuticsMD Q1 EPS $0.01 Up From $(0.06) YoY, Sales $724.000K Up From $393.000K YoY
TherapeuticsMD (NASDAQ:TXMD) reported quarterly earnings of $0.01 per share. This is a 116.67 percent increase over losses of $(0.06) per share from the same period last year. The company reported $724.000 thousand in
05-13 05:19
TherapeuticsMD Reports Quarterly Profit, Evaluates Strategic Alternatives
TherapeuticsMD ( ($TXMD) ) has provided an update. TherapeuticsMD, Inc. reporte...
05-13 04:47
TherapeuticsMD Explains Brief Delay In Annual Filing
TherapeuticsMD ( ($TXMD) ) has released a notification of late filing. Therapeu...
04-01 23:39
TherapeuticsMD Narrows 2025 Loss, Advances Royalty Strategy
The latest announcement is out from TherapeuticsMD ( ($TXMD) ). On March 30, 20...
03-31 08:12
